| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213081 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 27 Pages |
Abstract
In this randomized prospective study, there were stable QoL changes in patients receiving HIMRT or CIMRT. Our results add to the growing body of literature suggesting that HIMRT may be an acceptable treatment modality in clinically localized prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Talha MD, Tianyu MS, Elizabeth A. PhD, Matthew E. MD, Lora S. MD, Mark A. MD, PhD, Richard E. MD, Robert A. PhD, Robert G. MD, Charlie PhD, David MD, Daniel M. MD, Alan MD, PhD, Eric M. MD,